Results of the 2022 ECFA Early-Career Researchers Panel survey on career prospects and diversity

International audienceThis document presents the outcomes of a comprehensive survey conducted among early career researchers (ECRs) in academic particle physics. Running from September 24, 2022, to March 3, 2023, the survey gathered responses from 759 ECRs employed in 39 countries. The study aimed to gain insights into the career prospects and experiences of ECRs while also delving into diversity and sociological aspects within particle physics research. The survey results are presented in a manner consistent with the survey choices. The document offers insights for the particle physics community, and provides a set of recommendations for enhancing career prospects, fostering diversity, and addressing sociological dimensions within this field

The ECFA Early Career Researcher's Panel: composition, structure, and activities, 2021 -- 2022

The European Committee for Future Accelerators (ECFA) Early Career Researcher's (ECR) panel, which represents the interests of the ECR community to ECFA, officially began its activities in January 2021. In the first two years, the panel has defined its own internal structure, responded to ECFA requests for feedback, and launched its own initiatives to better understand and support the diverse interests of early career researchers. This report summarises the panel composition and structure, as well as the different activities the panel has been involved with during the first two years of its existence

The ECFA Early Career Researcher's Panel: composition, structure, and activities, 2021 -- 2022

The European Committee for Future Accelerators (ECFA) Early Career Researcher's (ECR) panel, which represents the interests of the ECR community to ECFA, officially began its activities in January 2021. In the first two years, the panel has defined its own internal structure, responded to ECFA requests for feedback, and launched its own initiatives to better understand and support the diverse interests of early career researchers. This report summarises the panel composition and structure, as well as the different activities the panel has been involved with during the first two years of its existence

The ECFA Early Career Researcher's Panel: composition, structure, and activities, 2021 -- 2022

The European Committee for Future Accelerators (ECFA) Early Career Researcher's (ECR) panel, which represents the interests of the ECR community to ECFA, officially began its activities in January 2021. In the first two years, the panel has defined its own internal structure, responded to ECFA requests for feedback, and launched its own initiatives to better understand and support the diverse interests of early career researchers. This report summarises the panel composition and structure, as well as the different activities the panel has been involved with during the first two years of its existence

The ECFA Early Career Researcher's Panel: composition, structure, and activities, 2021 -- 2022

The European Committee for Future Accelerators (ECFA) Early Career Researcher's (ECR) panel, which represents the interests of the ECR community to ECFA, officially began its activities in January 2021. In the first two years, the panel has defined its own internal structure, responded to ECFA requests for feedback, and launched its own initiatives to better understand and support the diverse interests of early career researchers. This report summarises the panel composition and structure, as well as the different activities the panel has been involved with during the first two years of its existence

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

Background and Objectives To investigate the genetic determinants of the most common type of antibody-mediated autoimmune encephalitis, anti-NMDA receptor (anti-NMDAR) encephalitis. Methods We performed a genome-wide association study in 178 patients with anti-NMDAR encephalitis and 590 healthy controls, followed by a colocalization analysis to identify putatively causal genes. Results We identified 2 independent risk loci harboring genome-wide significant variants (p = 2.2), 1 on chromosome 15, harboring only the LRRK1 gene, and 1 on chromosome 11 centered on the ACP2 and NR1H3 genes in a larger region of high linkage disequilibrium. Colocalization signals with expression quantitative trait loci for different brain regions and immune cell types suggested ACP2, NR1H3, MADD, DDB2, and C11orf49 as putatively causal genes. The best candidate genes in each region are LRRK1, encoding leucine-rich repeat kinase 1, a protein involved in B-cell development, and NR1H3 liver X receptor alpha, a transcription factor whose activation inhibits inflammatory processes. Discussion This study provides evidence for relevant genetic determinants of antibody-mediated autoimmune encephalitides outside the human leukocyte antigen (HLA) region. The results suggest that future studies with larger sample sizes will successfully identify additional genetic determinants and contribute to the elucidation of the pathomechanism